agilon health Statistics
Total Valuation
agilon health has a market cap or net worth of $942.20 million. The enterprise value is $722.40 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 16.66 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 16.66M |
| Shares Outstanding | 16.66M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 2.13% |
| Owned by Institutions (%) | 211.23% |
| Float | 10.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | 0.17 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 7.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.04 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.94 |
Financial Efficiency
Return on equity (ROE) is -109.59% and return on invested capital (ROIC) is -65.50%.
| Return on Equity (ROE) | -109.59% |
| Return on Assets (ROA) | -14.36% |
| Return on Invested Capital (ROIC) | -65.50% |
| Return on Capital Employed (ROCE) | -169.80% |
| Weighted Average Cost of Capital (WACC) | 16.97% |
| Revenue Per Employee | $6.80M |
| Profits Per Employee | -$414,186 |
| Employee Count | 856 |
| Asset Turnover | 3.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.08 million in taxes.
| Income Tax | 1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.62% in the last 52 weeks. The beta is 2.30, so agilon health's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | -50.62% |
| 50-Day Moving Average | 19.37 |
| 200-Day Moving Average | 22.23 |
| Relative Strength Index (RSI) | 83.38 |
| Average Volume (20 Days) | 469,134 |
Short Selling Information
The latest short interest is 1.00 million, so 6.01% of the outstanding shares have been sold short.
| Short Interest | 1.00M |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 6.01% |
| Short % of Float | 9.28% |
| Short Ratio (days to cover) | 3.29 |
Income Statement
In the last 12 months, agilon health had revenue of $5.82 billion and -$354.54 million in losses. Loss per share was -$21.38.
| Revenue | 5.82B |
| Gross Profit | -145.73M |
| Operating Income | -394.97M |
| Pretax Income | -372.46M |
| Net Income | -354.54M |
| EBITDA | -380.16M |
| EBIT | -394.97M |
| Loss Per Share | -$21.38 |
Full Income StatementBalance Sheet
The company has $231.41 million in cash and $30.03 million in debt, with a net cash position of $201.39 million or $12.09 per share.
| Cash & Cash Equivalents | 231.41M |
| Total Debt | 30.03M |
| Net Cash | 201.39M |
| Net Cash Per Share | $12.09 |
| Equity (Book Value) | 181.43M |
| Book Value Per Share | 10.93 |
| Working Capital | 48.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.05 million and capital expenditures -$12.49 million, giving a free cash flow of -$62.54 million.
| Operating Cash Flow | -50.05M |
| Capital Expenditures | -12.49M |
| Depreciation & Amortization | 14.81M |
| Net Borrowing | -3.50M |
| Free Cash Flow | -62.54M |
| FCF Per Share | -$3.75 |
Full Cash Flow StatementMargins
Gross margin is -2.50%, with operating and profit margins of -6.79% and -6.09%.
| Gross Margin | -2.50% |
| Operating Margin | -6.79% |
| Pretax Margin | -6.40% |
| Profit Margin | -6.09% |
| EBITDA Margin | -6.53% |
| EBIT Margin | -6.79% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | -38.38% |
| FCF Yield | -6.77% |
Analyst Forecast
The average price target for agilon health is $51.19, which is -9.49% lower than the current price. The consensus rating is "Buy".
| Price Target | $51.19 |
| Price Target Difference | -9.49% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 3.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
